1049 ET - Procter & Gamble could be poised to accelerate its organic sales growth after a challenging first half to its fiscal year, JPMorgan analyst Andrea Teixeira writes in a note, upgrading the stock to overweight. "At the earnings call Thursday morning, management gave much needed and hoped for reassurance that the company is on the right track to sequentially improve OSG from flat in FQ2 (1% in F1H) to about 2-3% in F2H," she writes. There are execution risks, she writes, but several factors are looking up for the back half of the fiscal year: underlying category growth improvement, the company lapping tough comps leaving the second quarter, and intervention tactics to stimulate growth that proved successful internationally. The worst seems to be behind, she writes. Procter & Gamble is up 1%.(elias.schisgall@wsj.com)
(END) Dow Jones Newswires
January 23, 2026 10:49 ET (15:49 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments